IM Cannabis (IMCC) Liabilities from Discontinued Operations (2022)
IM Cannabis (IMCC) posted quarterly Liabilities from Discontinued Operations of 33440104.0 for Q3 2022.
IM Cannabis (IMCC) Liabilities from Discontinued Operations (2022) Analysis & Trends
IM Cannabis' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 33440104.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 33.44 Mn |
| Sep 30, 2022 | 33.44 Mn |